China Pharma subsidiary acquires Ipragliflozin patent for $9.8M in stock

CHINA PHARMA HOLDINGS, INC.

Hainan Helpson enters Technology Transfer Agreement to acquire Ipragliflozin tablet patent from Juan Zhang.
Total consideration: $9.8 million paid in 7,000,000 restricted CPHI shares at $1.40 per share.
Transferor to provide technical services including product R&D, registration materials, and application.
Shares issued under Regulation S to non-U.S. person, unregistered and exempt from Securities Act registration.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

CHINA PHARMA HOLDINGS, INC. issued 7,000,000 restricted shares of Common Stock of common stock to Juan Zhang for $9.8 million, which will be paid in the form of common stock.

Security: common stock
Shares: 7,000,000 restricted shares of Common Stock
Purchaser: Juan Zhang
Consideration: $9.8 million, which will be paid in the form of common stock

Exact text from the filing

research and development, writing of registration materials, registration application and other technical services. The transfer price as contemplated by the Agreement is $9.8 million, which will be paid in the form of common stock of the Company, par value $0.001 per share (the “ Common Stock ”), at $1.40 per share. transfer price as contemplated by the

View on SEC.gov

Browse all equity issuances →

CHINA PHARMA HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-25-125299

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.